DatasetName,NONO_M(410) NONO_M(418) NONO_M(424) NONO_M(428) NONO_M(450) NONO_S(196) NONO_T(410) NONO_T(424) NONO_T(428) NONO_T(450) NONO_T(6),NONO_S(147) NONO_S(149) NONO_S(188) NONO_S(262) NONO_S(3) NONO_T(15) NONO_T(151) NONO_T(16) NONO_T(351) NONO_T(361) NONO_T(418) NONO_T(440),NONO_C(147) NONO_T(434)
RM2024_Intensity D4-1___3,,,
RB2022_4_PostEndurance,,,
FSO2013_Ratio M/L normalized Rep3,,0.4902598619747158,
SR2019_MCF7_Biol_repl_3,,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,
SR2019_LM2_Biol_repl_1,,,
RCJD2014_15min_1,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,0.6402122372786135,,
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,0.633505155864256,,
RKK2015_TNF-α/basal,,,
JJ2018_Ratio H/M normalized pP2,0.6034676225372543,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,,,
ZX2022_Control Replicate 2,0.5925970172350307,,
HS2024_6_B_T3,,,
JW2015_Intensity pre1,,,
IMM2018_normalised rep. int. Empty-3,,,
AMK2021_30R_p5,,,
FSO2013_Ratio M/L normalized Rep1,,0.47240358422822587,
SR2019_MDAMB231_Biol_repl_4,,,
GF2025_P2_Sph,0.6187344565538578,0.45174109475790236,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,0.6302134618999771,0.46486964325577446,
DB2022_Intensity L2,,,
TM2022_mock.4h.C,,,
AST2020_anti-CD3.2,0.6122764501832224,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,
HS2024_7_B_N1,,,
FSO2013_Ratio M/L normalized Rep1___1,,0.47244071603994175,
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,,,
RM2024_Intensity D6-1,,,
RB2022_8_RecoverySprint,,0.4672214261618035,
RB2022_5_PreEndurance,,0.47023920240476635,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,
EP2017_Untreated R#4 normalized log2 ratio,0.6343053706724063,,
WZ2023_Pu_010_30min,0.6592827652458491,,0.2239316789078803
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,,,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,0.635742428147063,,
RB2022_8_RecoveryEndurance,,0.4696060718433941,
KBE2022_Log2_Ex_14_U,0.6303159731347421,0.47153234871791155,
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,0.6360275235470423,0.49028427357529863,
JJ2018_Ratio H/L normalized___1,0.6154245439577006,,
ZQ2022_C2,,,
RB2022_5_PreSprint,,0.4655957874505614,
PG2020_Intensity 8h_C,0.5984223261348123,0.46104478495664597,
AH2018_SILAC_MR_2_N,0.6387731178148297,,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,0.6199255505789423,,
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),0.6403769684782143,,
UK2020_HCM_2,0.6110504022680676,,
FSO2013_Ratio H/L normalized Rep2___2,,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.6288320824382431,,
RM2024_Intensity D4-3___3,,,
RB2022_5_PreStrength,,0.4734804078558317,
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,,,
RB2022_5_PostStrength,,0.48141601179464616,
GF2025_P6_Sph,0.6214927506668261,0.44123155110039236,
RB2022_2_PreSprint,,0.4697342592448203,
ZX2022_CB treated Replicate 3,0.5921780693622704,,
RM2024_Intensity D6-2___3,,,
WZ2023_Pe_025_10min,0.6760208872807809,,0.20423352714920046
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,0.6132669984293387,,
KBE2022_Log2_Ex_34_U,0.6277860314685398,0.4634324458680563,
WZ2023_Pu_005_10min,0.670688674617245,,0.2203410817774512
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,0.6292296670949926,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,,
WZ2023_Pu_025_30min,0.6593473635632306,,0.25844511067626386
AH2018_SILAC_MR_2_X,0.6353033969629677,,
HS2024_4_PD_T2,,,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,,0.46592563254627994,
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,0.635210262381046,0.47493141591201526,
FR2021_Norm.Intensity.B,,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,,0.4779954023761607,
EJN2021_3_Rest_Basal,,0.46939607177932313,
CR2017_Ratio Replicate 1.3,0.6326450690547999,0.46288664480375036,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,,,
AH2018_SILAC_3_X,0.6326459419085825,,
JJ2018_Ratio M/L normalized pP3,0.621153218333827,,
AH2018_SILAC_M_2_N,0.6347917366916265,0.46454600350575803,
HS2024_7_PD_T2,,,
FSO2013_Ratio H/L normalized Rep1___1,,0.4727320316591015,
AH2018_LFQ_1_C,0.6391872713599521,,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,0.6277298971701266,,
HS2024_3_B_N1,,,
RM2024_Intensity D4-2___3,,,
WZ2023_Pe_025_30min,0.6776457744642624,,0.20003470168231374
CK2022_11 40-1,0.6289899977848271,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,
AH2018_SILAC_2_X,0.6347346262831486,0.46421850260306036,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,0.6307340707637604,,
FSO2013_Ratio H/L normalized Rep2,,0.49190326652499977,
WZ2023_Pu_005_20min,0.6606876432589719,,0.23904447359621434
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,0.6283309745597077,0.4514469590803358,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,
HS2024_7_B_T3,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,0.6044007796087476,,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,,,
HS2024_9_B_T2,,,
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,,,
FSO2013_Ratio M/L normalized Rep3___2,,,
SR2019_BT549_Biol_repl_3,,,
RCJD2014_20min_mean,,,
FR2021_Norm.Intensity.H,,,
RB2022_2_PreStrength,,0.4698524924167256,
DB2022_LFQ intensity L1.2,,,
HS2024_4_B_N1,,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,0.6384032603615841,,
CK2022_1 200-1,0.634843505363517,0.4774121914400022,
PG2020_Intensity Mock_10h_D,0.6261600927457212,,
SR2019_MCF10A_Biol_repl_2,,,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,
EP2017_Mitotic R#2 normalized log2 ratio,0.6402807484517804,,
RCJD2014_5min_1,,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,,,
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,0.6212777490587945,0.47016740105779026,
PG2020_Intensity 2h_C,0.6252291810414209,,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,0.5898591089380575,,
KBE2022_Log2_Ex_8_T,0.6256183442379896,0.470497401906425,
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,,,
RN2012_L11,,,
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,,,
HS2024_5_PD_T1,,,
AH2018_LFQ_M_2_C,0.6100492046704734,,
CK2022_3 40-1,0.6326735374945888,,
RBK2021_1260T Early,0.6337858350901452,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,,,
YA2020_Reporter_intensity_Cancer_No.5,0.6387399713819882,0.46777463152790055,
HH2022_Reporter intensity 8,,,
ZQ2022_N2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,0.6317901928209791,0.4727841988121515,
EJN2021_5_Rest_Basal,,0.4661351441065975,
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,0.6333364833909472,,
YA2020_Reporter_intensity_Normal_No.1,0.6315461717177931,0.46647279163756367,
HS2024_3_B_T1,,,
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,,0.4741594290036977,
RB2022_1_PostEndurance,,,
CR2017_Ratio Replicate 3,0.6072725306363723,0.488855169130552,
SR2019_Hs578T_Biol_repl_3,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,0.6229570850645638,,
RB2022_3_PostSprint,,0.4804159119598854,
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,0.6329964324274692,0.4433044583581646,
HS2024_8_I_T3,,,
CF2017_EOC 3,0.606074860132558,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,
HS2024_6_PD_T3,,,
DL2023_12h-2,,,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,,
WZ2023_Pu_010_20min,0.6608508555859771,,0.22218339803141895
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,0.6328146373218502,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,
CK2022_8 16-1,0.6400780913592548,,
KS2014_Intensity N3,0.6471973119139084,,
RB2022_4_RecoveryEndurance,,,
RB2022_5_RecoveryEndurance,,0.46655953264642297,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,0.6321251888196832,,
FSO2013_Ratio H/M normalized Rep2,,0.4904910358498369,
RAM2015_Log2 A,0.6160980447040988,,
HS2024_8_PD_T1,,,
JJ2018_Ratio H/L normalized pP2,0.618366078446251,,
CF2017_OSE 27,0.6304942585831923,,
KS2014_Intensity E15_2,0.6294648933092497,,
BS2014_Log2(Ratio H/L protein),0.6210448418748169,,
PG2020_Intensity 8h_A,0.6087681096289721,,
HS2024_7_I_T1,,,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,
SR2019_JIMT1_Biol_repl_1,,0.4613415341996879,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,,,
AH2018_SILAC_M_3_X,0.6324524547949578,,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,0.6281459019677329,,
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,0.6368285345975427,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,,,
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,0.6124922425045912,,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,0.6339557168221049,,
HS2024_6_B_N1,,,
KBE2022_Log2_Ex_27_T,0.627493191211426,0.4740859394416912,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,,,
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,,,
AH2018_SILAC_IT_3_X,0.6364115035558838,0.4614251774898149,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,0.6188102499009595,,
FSO2013_Ratio M/L normalized Rep2,,0.49528113089826586,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,,,
SR2019_HCC1954_Biol_repl_2,,0.45978930511476485,
CK2022_14 40-1,0.6300288141268582,,
RB2022_6_PreSprint,,0.47857061431378795,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,0.628498076833118,,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,0.6444298904819895,,
DL2023_control-1,,,
AR2021_ALG 10 μM,0.6484600392712304,,
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,0.6354439303178125,0.4788727135605624,
EJN2021_4_Rest_Ins,,0.4743804534934779,
RN2012_H05,,,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,0.6255195604362788,0.47769549967835173,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,,0.470535960004774,
EJN2021_1_Rest_Ins,,0.47226124388644636,
HH2022_Reporter intensity 3,,,0.2283174843521587
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,0.6345433629709883,0.47974505995897315,
JW2021_After_3,,,
GF2025_P8_Sph,0.6174274998048043,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,
JJ2018_Ratio M/L normalized pP2___1,0.6370398414718651,,
AH2018_SILAC_2_N,0.6347093215544958,0.46360940479077134,
CK2022_11 200-1,0.6324380295693505,0.47399605172803994,
CK2022_12 200-1,0.632215157666452,0.47536151567257495,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,,,
WZ2023_Su_010_20min,0.6567574859775832,,0.21227735344672655
AH2018_TMTMS2_2_N,0.6386321990406513,0.4917914339450083,
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,0.6312711239630767,0.4612265838129579,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.4682749454859252,
AH2018_TMTMS3_Pool,0.6350124650334138,0.4658193105227606,
KS2014_Intensity N4,0.6494060105986705,,
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,0.6490859090699042,,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,0.6249923067293088,,
CK2022_14 200-1,0.6348097848403209,0.47699940074433106,
SR2019_Hs578T_Biol_repl_1,,,
RB2022_7_PostSprint,,0.47969538514913546,
TM2022_mock.4h.A,,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,0.6268892970374093,0.46615139997935934,
AST2020_anti-CD3+PDL2.2,0.6123018654353038,,
PG2020_Intensity Mock_10h_A,0.6363717400171819,,
JW2021_After_2,,,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,,0.4741252863848722,
SR2019_LM2_Biol_repl_4,,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,0.6381278353293961,,
GF2025_P1_Adh,0.6284253277405724,0.4473968996112468,
GF2025_P1_Sph,0.6205138717872927,0.4556190282796046,
EJN2021_5_Ex_Basal,,0.47019659328787067,
HS2024_7_I_T3,,,
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,0.6679405441047778,,0.24063296434872727
CF2017_EOC 1,0.6272769344202962,,
CK2022_3 200-1,0.63499954718469,0.47895615017798215,
AH2018_LFQ_IT_3_C,0.6395170408994411,0.4590498932666724,
SR2019_Hs578T_Biol_repl_2,,,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),0.6402355133354547,,
RB2022_3_RecoverySprint,,,
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,
HS2024_6_PD_T2,,,
HS2024_5_B_T1,,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,,,
SR2019_MDAMB231_Biol_repl_2,,,
HS2024_3_B_T2,,,
RB2022_6_PreStrength,,0.47063074633674407,
CK2022_2 40-1,0.6318503834982855,,
RB2022_1_PostSprint,,0.47395122253752264,
CK2022_4 200-1,0.6355530065938283,0.4800157071688033,
JW2021_Before_2,,,
TM2022_S2.12h.A,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,0.6398536562339184,,
AR2021_ALG 1 μM,0.6153034604796958,,
HS2024_4_B_T1,,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,,,
EJN2021_1_Rest_Basal,,0.4723883187650566,
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,,,
CR2017_Ratio Replicate 3.2,0.6118591615007387,0.47978244878791676,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,
GF2025_P7_Adh,0.6288916992538787,0.4709616996177947,
CK2022_9 16-1,0.6352715058169663,,
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,,,
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,0.6314127120036391,,
CK2022_13 200-1,0.63414762841379,0.47708953160582457,
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,0.6273644618988592,,
CK2022_16 16-1,0.6388274961559323,,
FS2019_db/db3,,,
CK2022_15 40-1,0.6301258605958726,,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,0.6562237108233525,,0.20916676662059447
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,0.6303813904537595,0.4639383956107171,
AMK2021_Ctrl_p1,,,
AH2018_LFQ_IT_3_X,0.6347287995155545,0.46427255608404544,
HS2024_5_PD_T3,,0.4979150814110322,
AH2018_TMTMS3_3_X,0.6356942323566077,0.45104564593880164,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,
KBE2022_Log2_Ex_40_U,0.6291249775417609,0.4688928680858904,
AH2018_LFQ_M_1_N,0.6436208711310772,,
KBE2022_Log2_Ex_27_U,0.6274793764123497,0.47806769916618946,
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),,,
AH2018_SILAC_M_1_N,0.6322170479757673,,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,,,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,,0.4683398031564329,
YA2020_Reporter_intensity_Normal_No.4,0.6351581971323842,0.4710036894163607,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,0.6280076539979041,,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,0.6355457493299682,,
RN2012_L13,,,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,0.6255860290004032,0.47198684704469795,
SR2019_SKBR3_Biol_repl_3,,,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,,,
HS2024_6_I_T2,,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,,0.49104652135042165,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,0.6296563875422216,,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,,,
LY2019_P3+,0.60083368279405,,
HH2022_Reporter intensity 6,,,
RB2022_2_RecoveryStrength,,,
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,0.6321633515498847,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,0.6372237595176311,,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,,,
AH2018_TMTMS2_3_X,0.6368858642866069,0.4914937545033029,
GF2025_P3_Adh,0.6238076891250759,0.45685529048350965,
SR2019_JIMT1_Biol_repl_2,,0.4714189060148459,
AH2018_TMTMS2_1_C,0.6387666427755047,0.490979456492416,
RM2024_Intensity D0-1___2,,,
LY2019_P4+,0.6332220007060377,,
KBE2022_Log2_Ex_19_U,0.6325401089656263,0.4687711037693066,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,
RB2022_4_PostStrength,,,
LG2023_GSK3α-3_intensity,,,
YA2020_Reporter_intensity_Cancer_No.1,0.6176499202520397,,
AST2020_Control,0.6114051901784118,,
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,,0.49535101211134486,
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,0.6319298715426419,,
RB2022_5_RecoverySprint,,0.48129199884684953,
RB2022_7_RecoverySprint,,0.4767308450871924,
YA2020_Reporter_intensity_Normal_No.3,0.6367561961560254,0.4703694709312057,
HS2024_8_B_T2,,,
AH2018_LFQ_1_X,0.6338957136282241,,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,,,
FR2021_Norm.Intensity.M,,,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,0.6467296405762302,,
HH2022_Reporter intensity 1,,,0.20765880461293382
HH2022_Reporter intensity 2,,,0.21980770483495102
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,0.6349466870001946,0.4700298608970545,
SR2019_MCF7_Biol_repl_1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,,0.4502331118684855,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,,
EP2017_Untreated R#2 log2 ratio,0.5872025979848391,,
SR2019_LM2_Biol_repl_3,,,
RB2022_4_RecoveryStrength,,,
CR2017_Ratio Replicate 2,0.622893765032599,0.44615062534704625,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,,0.5010530853977316,
AR2021_KD 72h,0.6313606673709631,,
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,0.6287707418327865,0.47989693582780996,
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,0.6350058894318159,0.4670699122559961,
KBE2022_Log2_Ex_9_U,0.6285411106037119,0.47453337227613135,
AH2018_SILAC_M_3_N,0.6332639923533291,,
KBE2022_Log2_Ex_13_T,0.6269888139503956,0.4694394865840054,
RM2024_Intensity D0-3,,,
SR2019_SKBR3_Biol_repl_1,,,
PG2020_Intensity Mock_10h_C,0.5872403583997493,,
CF2017_OSE 29,0.6340545063029265,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,,,
HS2024_7_B_N2,,,
PG2020_Intensity 10h_A,0.5980071429678072,,
RN2012_L12,,,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,0.6369897238770487,,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,,,
FSO2013_Ratio H/M normalized Rep1___1,,0.4563138112083029,
JW2015_Intensity cap2,,,
BS2014_Log2(Ratio H/L normalized Rep_2),0.6401531310331573,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,0.6319269237031229,,
RB2022_7_RecoveryEndurance,,0.4754227465654486,
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,,0.47927947625504713,
TM2022_S2.12h.B,,,
RN2012_L15,,0.4756240393535342,
KS2014_Intensity pY_PV3,,,
TM2022_S2.4h.B,,,
PG2020_Intensity 4h_A,0.6298280974679069,,
FSO2013_Ratio H/M normalized Rep2___2,,,
TM2022_mock.4h.B,,,
KBE2022_Log2_Ex_24_U,0.6299319448871482,0.471057241284013,
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,0.6266033598624617,,
RB2022_1_PreSprint,,,
HS2024_4_I_N1,,,
CK2022_7 200-1,0.635358948527209,0.4746407392395844,
CK2022_5 200-1,0.6348750253146377,0.47191103863882883,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,
FSO2013_Ratio H/L normalized Rep2___1,,0.4926715034468072,
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,,,
AH2018_LFQ_2_C,0.6385702032462773,,
AH2018_SILAC_MR_1_X,0.64335572397265,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,,,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,0.630397338689416,0.46603379883396606,
AH2018_SILAC_3_C,0.6369845709398475,,
EJN2021_5_Rest_Ins,,0.4740740831799877,
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,,
DB2022_LFQ intensity L2.1,,,
FSO2013_Ratio H/M normalized Rep1,,0.4549379306990838,
CK2022_4 16-1,0.6403102512216755,,
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,,,
EJN2021_2_Ex_Ins,,0.46667069855164595,
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,0.6425171532203234,,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,0.6327460180985294,,
JJ2018_Ratio M/L normalized pP2,0.6370874761010772,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,0.618368761550511,,
FSO2013_Ratio H/L normalized Rep3,,0.4919580327197381,
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,
JJ2018_Ratio M/L normalized,0.6191129703681105,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,,,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,,,
KBE2022_Log2_Ex_9_T,0.6284290842001966,0.4733682020922479,
AH2018_SILAC_IT_2_N,0.6348108777296751,0.4788265621818193,
AH2018_SILAC_IT_1_X,0.6411036802914446,0.4569998586033482,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,,,
UK2020_UA_2,0.6111343145016792,,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,0.6238217527219502,0.45025013654763035,
WZ2023_Pe_025_20min,0.6753081099790257,,0.19225890939206144
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,0.6404837940253438,,
HS2024_4_I_N2,,,
AH2018_TMTMS2_3_N,0.6389420383810699,0.4945709930931264,
RN2012_H06,,0.4773530950587579,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,,,
WZ2023_Su_005_30min,0.6620014775411551,,0.2294664706844231
SR2019_HCC1419_Biol_repl_4,,,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,,0.4654293239330774,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,0.6111572134156009,,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,0.5997216611017603,0.49393099123865253,
WZ2023_Su_025_10min,0.6667498276760861,,0.1803332526750141
AH2018_LFQ_IT_4_X,0.6326361215140451,,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,,,
RM2024_Intensity D6-3,,,
WZ2023_Su_005_20min,0.6609284556054416,,0.23071341525327033
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,
SFR2015_HL_log2_ratio_avg_a,0.6287426939862408,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,,0.47531824215272006,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,0.6232987188368329,,
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,,,
KS2014_Intensity,0.649543159994759,,
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,0.6203691234401851,0.463354335666899,
LY2019_P7+,0.6051725807998027,,
EP2017_Untreated R#1 normalized log2 ratio,0.613666710837586,,
RN2012_L10,,,
PG2020_Intensity 4h_C,0.6298944781134211,,
EP2017_Mitotic R#3 normalized log2 ratio,0.6498830123619945,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,,,
KBE2022_Log2_Ex_24_T,0.6275285376499492,0.4686767010188677,
RB2022_8_PostStrength,,0.4650305866385768,
AH2018_SILAC_IT_2_X,0.6363939028996897,0.4619624463306124,
HS2024_4_B_T3,,,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,,0.4694732344900612,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,0.6183430721651584,,
HS2024_8_I_T2,,0.46638779337468544,
KBE2022_Log2_Ex_6_U,0.6260822531731557,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,
CR2017_Ratio Replicate 1.1,0.6113668720674521,0.45033544387845953,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,0.6348966769145675,0.4775700288660363,
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,0.6705899881462051,,
GF2025_P9_Sph,0.6276251163943661,0.4506223963612181,
CK2022_6 200-1,0.635071581989579,0.46958142933248914,
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,0.6416712412741786,0.4654001047877478,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,,,
JW2015_Intensity cap3,,,
SR2019_HCC1954_Biol_repl_1,,0.4792001303914763,
HS2024_4_I_T2,,,
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,,,
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,,,
HS2024_3_B_T3,,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,0.655585421405902,,
PG2020_Intensity 2h_D,0.616743508179471,,
EP2017_Untreated R#3 normalized log2 ratio,0.6194480187955151,,
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,0.6351930399854878,0.47300798087753265,
KS2014_Intensity pY_C4,,,
CR2017_Ratio Replicate 3.5,0.6181846795612758,0.48915085745360404,
RB2022_7_PostEndurance,,,
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,
TM2022_mock.12h.A,,,
JJ2018_Ratio H/L normalized pP1,0.6102761855593869,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.6310067299010654,,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,,,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,
AH2018_SILAC_2_C,0.6395474609399711,0.45903812621031337,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,,,
KBE2022_Log2_Ex_29_T,0.6281340045733931,0.474958751316781,
HS2024_7_I_T2,,,
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,
HS2024_6_B_T2,,,
AMK2021_45I_p5,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,,0.47376689510782516,
FR2021_Intensity.M,,,
RB2022_2_PostSprint,,0.47615755242004115,
AH2018_SILAC_MR_3_N,0.6412519862593865,,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,0.6358348402014806,,
PG2020_Intensity CT_C,0.6269443839108058,,
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,,,
KS2014_Intensity pY_PV4,,,
KBE2022_Log2_Ex_39_U,0.6308451368184005,,
EP2017_Untreated R#3 log2 ratio,0.6190184100325821,,
RB2022_2_PostStrength,,0.47050321760417235,
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,0.6157317918883077,0.49185882053871105,
HS2024_8_PD_T2,,,
FS2019_Ctr2,,,
RB2022_6_PreEndurance,,0.4709644910665969,
FR2021_Norm.Intensity.G,,,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,
RM2024_Intensity D4-3,,,
HS2024_8_B_N1,,0.45652069594615563,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,0.6281057216204204,,
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,,,
RB2022_3_PreSprint,,0.46843858267922706,
CR2017_Ratio Replicate 2.3,0.6228978101086663,0.4708379978434479,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,0.6291385508127947,0.44495271623175753,
YA2020_Reporter_intensity_Normal_No.2,0.6339348679569363,0.4698368294985355,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,,,
HS2024_3_PD_T3,,,
AMK2021_120R_p3,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,,,
RAM2015_Log2 C,0.6041583984544139,,
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,0.6421664444244777,,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,0.6299785236556906,0.46890556445485526,
CK2022_2 16-1,0.6384786814803364,,
RAM2015_Log2 B,0.6058978968824937,,
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,,,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,0.6383909970246893,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,,,
UK2020_HCM_5,0.6113623205812515,,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,,,
HS2024_7_PD_T3,,,
PG2020_Intensity Mock_10h_B,0.6239295463773734,,
WZ2023_Su_025_30min,0.6584422470003419,,0.20741097805903286
AH2018_LFQ_4_N,0.639845295972271,,
CR2017_Ratio Replicate 1.2,0.6354330609941071,0.4501894698283165,
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,,,
HS2024_8_I_N1,,0.45261142089901507,
AMK2021_Ctrl_p3,,,
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,,,
AH2018_SILAC_M_1_X,0.6302533537136717,,
RB2022_7_PreEndurance,,0.4681983227657078,
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,,,
LY2019_P6+,0.6059919249607258,,
DB2022_LFQ intensity R2,,,
GF2025_P6_Adh,0.619614197130442,0.5174877480512184,
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,,,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,,0.47990188847803994,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,0.6330607422039409,0.46502335016069374,
SR2019_Hs578T_Biol_repl_4,,,
RB2022_8_PreStrength,,0.47106099020900066,
KS2014_Intensity C5,0.6273399680726577,,
RM2024_Intensity D0-1,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,,
GF2025_P9_Adh,0.6248929188299058,0.4778658123185429,
RB2022_3_PostStrength,,0.47940343837440835,
TM2022_S2.8h.A,,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,,,
SR2019_BT549_Biol_repl_1,,,
AH2018_LFQ_M_4_N,0.6413776135147805,,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,0.6058164852697115,0.4500705669954397,
AH2018_LFQ_2_X,0.6026650439507224,,
PG2020_Intensity 2h_B,0.6233882366304777,,
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,,,
KS2014_Intensity E15_3,0.6288233114984737,,
GF2025_P3_Sph,0.6087555427510712,0.452920059781974,
DB2022_LFQ intensity L2,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,0.6334698682508825,,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.4759106716404728,
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,0.6388584863112586,0.4788321615082089,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,,,
JJ2018_Ratio M/L normalized pP1,0.6073706673060167,,
CR2017_Ratio Replicate 2.4,0.6162752292528566,0.5005011975996689,
ZQ2022_N1,,,
LY2019_P6-,0.6112611608249647,,
RM2024_Intensity D2-3,,,
UK2020_HCM_1,0.6128664171365656,,
JW2015_Intensity pre2,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,,0.47860552656532684,
AH2018_LFQ_3_N,0.6344441165512181,,
RKK2015_TNF-α/IKKb,,,
SFR2015_HL_log2_ratio_std_b,0.623778375216835,,
UK2020_UA_1,0.6125568080394497,,
KBE2022_Log2_Ex_13_U,0.6256729588943294,0.4706334757970431,
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,,
RB2022_1_RecoverySprint,,0.4757028667920136,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,
JJ2018_Ratio H/L normalized pP3,0.6414841909046449,,
CK2022_7 40-1,0.6320990661842104,,
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,0.628313588393177,,
SR2019_BT549_Biol_repl_2,,,
RM2024_Intensity D4-2,,,
DB2022_LFQ intensity R2.2,,,
JJ2018_Ratio H/L normalized,0.615527367300809,,
RB2022_5_PostEndurance,,,
HS2024_5_PD_T2,,0.46884616862609696,
WZ2023_Su_025_20min,0.6580576402939381,,0.1924847718489427
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,,,
LY2019_P8-,0.6212356129494223,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,
FSO2013_Ratio H/L normalized Rep1,,0.47166768339998527,
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,
CK2022_13 40-1,0.6302599111176193,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,
RN2012_H02,,,
PG2020_Intensity 10h_D,0.6084932180794221,0.45278917748968056,
RB2022_8_PreEndurance,,0.46102398918078263,
HS2024_3_B_N2,,,
EJN2021_4_Ex_Ins,,0.4676654953799128,
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,,0.46893780596209206,
EP2017_Pervanadate R#3 log2 ratio,0.6282097674457018,,
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,,,
RB2022_6_PostStrength,,0.4823407943447644,
AH2018_SILAC_MR_3_C,0.6432868519731632,,
AH2018_LFQ_M_4_C,0.6460578288647286,,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,
RN2012_H04,,,
CK2022_6 40-1,0.6322929644071127,,
DB2022_LFQ intensity R2.1,,,
KBE2022_Log2_Ex_42_U,0.6285062940134485,,
LY2019_P3-,0.6093460775937108,0.46116309585643234,
FR2021_Intensity.A,,,
EJN2021_3_Ex_Ins,,0.47323813860003394,
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,0.6659397540826624,,0.21965317204111984
HS2024_8_PD_T3,,,
EJN2021_3_Ex_Basal,,0.476268921077832,
AST2020_Control.1,0.6124003337651993,,
JW2015_Intensity cap1,,,
PG2020_Intensity CT_A,0.6235854274250229,,
FS2019_Ctr3,,,
WZ2023_Pu_025_20min,0.6645520880594447,,0.23514580488212727
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,0.6311105564986683,0.45150694528857205,
RB2022_1_RecoveryStrength,,,
SR2019_HCC1954_Biol_repl_4,,0.46224638509694177,
FR2021_Norm.Intensity.N,,,
HS2024_5_B_N1,,0.46244811532876007,
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,0.6422513657738589,0.49395548817953383,
RB2022_4_PreSprint,,,
DB2022_Intensity R2,,,
AH2018_TMTMS2_Pool,0.6299705292658028,0.4623766388900053,
HS2024_8_I_N2,,0.4579353194562443,
RB2022_3_RecoveryStrength,,,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,0.634134885553991,,
LY2019_P8+,0.6371122665058511,,
RB2022_2_RecoveryEndurance,,0.4681807735334311,
JJ2018_Ratio H/M normalized pP2___1,0.6028478845375789,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,,,
KS2014_Intensity pY_PV1,,,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.4740521600776429,
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,0.6386896240894184,,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,
KBE2022_Log2_Ex_28_U,0.6292617244365495,,
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,0.6318991878227075,,
LY2019_P2-,0.6133036574816028,,
AH2018_LFQ_IT_1_X,0.6300037472777711,,
JJ2018_Ratio H/L normalized pP3___1,0.6417796615350718,,
RB2022_8_RecoveryStrength,,0.4607348394422908,
WZ2023_Pe_005_20min,0.6670669260144254,,0.23036758123498313
AST2020_Control.2,0.6127720738901964,,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,
CK2022_4 40-1,0.6338306103505608,,
SR2019_MCF10A_Biol_repl_4,,,
KS2014_Intensity pY_C5,,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,0.6268627528561571,,
HS2024_5_B_T2,,,
HS2024_6_I_T1,,,
HS2024_5_B_T3,,,
JJ2018_Ratio H/M normalized pP1___1,0.6237292614865148,,
KBE2022_Log2_Ex_36_U,0.6280997822394085,0.488791191293455,
AH2018_TMTMS3_3_N,0.6264825808718286,0.46709809741059843,
SR2019_HCC1419_Biol_repl_2,,,
FR2021_Intensity.N,,,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,0.6407563148188777,,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,0.6501502944128444,,
KBE2022_Log2_Ex_36_T,0.6285385865121644,0.4820453307335437,
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,0.6631264406552612,,0.22937384210212614
KS2014_Intensity C2,0.6261528426784758,,
FSO2013_Ratio H/L normalized Rep1___2,,,
RM2024_Intensity D2-2,,,
KBE2022_Log2_Ex_42_T,0.6293237321539163,,
CK2022_9 200-1,0.6326416519652903,0.4739756591351197,
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,,,
CK2022_10 200-1,0.6323057704414083,0.47341699133556125,
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,,,
RBK2021_1332T Late,0.6063044576983819,,
LY2019_P1-,0.6318474048681085,,
RKK2015_TNF-α/basal.1,,,
RKK2015_TNF-α/TNF-α+SC-514,,,
CR2017_Ratio Replicate 2.5,0.6172864620219949,0.49070050289193184,
HS2024_3_I_T3,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,0.6258044969247213,,
ZQ2022_C3,,,
EJN2021_3_Rest_Ins,,0.4713492266423202,
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,0.628965638618579,,
FSO2013_Ratio H/M normalized Rep3___2,,,
RM2024_Intensity D6-2,,,
EP2017_Untreated R#1 log2 ratio,0.6133098609006986,,
RKK2015_SC-514/basal,,,
RM2024_Intensity D6-1___3,,,
WZ2023_Pu_010_10min,0.6607829109106517,,0.23987142695344987
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,,,
HS2024_5_I_T3,,,
KS2014_Intensity N1,0.6451828444352202,,
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,,,
CR2017_Ratio Replicate 1,0.6035253860012877,0.457305296395674,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,
JJ2018_Ratio H/M normalized pP3,0.6385004199969837,,
AH2018_SILAC_MR_2_C,0.6351825483987287,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,
PG2020_Intensity 2h_A,0.6259362026339418,,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,0.6359444473482166,,
JJ2018_Ratio H/M normalized___1,0.6265542980591707,,
RCJD2014_15min_2,,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,,,
HS2024_5_B_N2,,0.5039251661059807,
HS2024_5_I_N1,,0.5052162197973222,
HS2024_6_I_N1,,,
AR2021_KD 48h,0.6446099479393615,,
FR2021_Intensity.B,,,
RB2022_3_PreEndurance,,0.4658984870403348,
HS2024_5_I_T1,,,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,,,
AST2020_anti-CD3,0.6122740329081262,,
SR2019_MDAMB231_Biol_repl_1,,,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,0.6663961118578948,,0.21809844743141305
KBE2022_Log2_Ex_29_U,0.628164378755641,0.4760109282069703,
HS2024_7_B_T1,,,
AH2018_LFQ_M_2_X,0.6103073128322978,,
AH2018_LFQ_IT_4_N,0.6333180277249562,,
CK2022_15 200-1,0.6341541329305449,0.47769779265718554,
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,0.626683491411907,,
JJ2018_Ratio M/L normalized pP3___1,0.6212087654819244,,
KBE2022_Log2_Ex_34_T,0.6275627696942073,0.4641364347401256,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,
LY2019_P2+,0.6074886565951227,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,
CK2022_2 200-1,0.6336991055117501,0.4793683162167454,
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,0.6587940031722829,,0.22858020865630135
RN2012_H01,,,
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,,,
KS2014_Intensity pY_E5_3,,,
MM2018_Ratio H/L replicate 3,0.6464502358429849,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.6239572442677814,,
HS2024_8_B_T3,,0.4451924225145036,
YA2020_Reporter_intensity_Cancer_No.3,0.6357672226039088,0.47004010392494355,
KBE2022_Log2_Ex_44_U,0.6292241095096573,0.46379643964165024,
WZ2023_Pe_010_20min,0.6708304063160183,,0.2312029198132769
KS2014_Intensity pY_C6,,,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,,,
RB2022_3_PreStrength,,0.478489863718067,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,,
RCJD2014_10min_mean,,,
KS2014_Intensity C1,0.6288479407010196,,
FSO2013_Ratio H/M normalized Rep3___1,,0.5013093701683023,
AH2018_SILAC_M_3_C,0.6366273414929728,,
RKK2015_TNF-α+IKKb/TNF-α,,,
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,
AH2018_SILAC_M_2_C,0.6397363992749556,0.45987904159618437,
AH2018_SILAC_M_2_X,0.6341263035830856,0.46415598701905614,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,0.6276208894738402,,
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,0.6567536989615709,,0.22075770849539011
PG2020_Intensity 6h_C,0.6173192699054745,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,0.6069637662968158,,
AH2018_LFQ_M_3_N,0.6363256608712065,,
VOI2024_0.1uM 24 h_2 mono,,,
AH2018_TMTMS2_3_C,0.6409164614126778,0.4928143257627557,
CK2022_15 16-1,0.6385240618207327,,
CK2022_3 16-1,0.638919023296105,,
LY2019_P4-,0.6273056218422731,0.4977356020868717,
FSO2013_Ratio H/L normalized Rep3___2,,,
KS2014_Intensity pY_PV2,,,
HS2024_3_I_N2,,,
GF2025_P8_Adh,0.6230996596839581,0.49997937720539015,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,0.6243073303872007,0.4653779398234392,
CK2022_10 16-1,0.6358809798889133,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.4691387033715313,
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,,
DB2022_Intensity R1,,,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,0.6105120637482471,,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,,,
DB2022_LFQ intensity L2.2,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,0.6701147428477422,,
EJN2021_2_Ex_Basal,,0.47281881832899053,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,
CF2017_FTE 16,0.6319688328112399,,
AR2021_L41 10 μM,0.6436864499167668,,
CF2017_EOC 2,0.6114850427855159,,
RB2022_6_PostEndurance,,,
AH2018_SILAC_1_N,0.6321254511553551,,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,0.6112825706619107,,
RB2022_7_PreSprint,,0.47054879004376066,
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,,,
CK2022_6 16-1,0.6398853819045205,,
ZX2022_CB treated Replicate 1,0.5905013586627033,,
BS2014_Log2(Ratio H/L normalized Rep_3),0.6407048303846709,,
TM2022_mock.12h.C,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,,,0.23284260342027008
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,,0.4665486651825965,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,0.6362974395080271,0.49033428639421,
AR2021_L41 1 μM,0.6275496693770866,,
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,0.6382283533387543,0.49151319817617384,
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,0.5908714331662245,,
KS2014_Intensity C4,0.6267242843405462,,
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,0.6342635798358793,0.47209529896433094,
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,,,
HS2024_7_B_T2,,,
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,0.6436412394292944,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,
YA2020_Reporter_intensity_Cancer_No.2,0.6366097979633353,0.4603685322880449,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,,0.4657323309466454,
AH2018_SILAC_IT_3_C,0.6326920003315467,0.47973408202670753,
WZ2023_Pu_025_10min,0.6630695068497576,,0.2444781398822754
RM2024_Intensity D2-2___3,,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,,,
FSO2013_Ratio M/L normalized Rep3___1,,0.4900197676815065,
SR2019_JIMT1_Biol_repl_4,,0.4656648771601369,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,0.6205890298279805,,
JJ2018_Ratio H/L normalized pP1___1,0.6087853031598315,,
WZ2023_Pe_010_30min,0.6693860816919727,,0.23774142559511807
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,0.6347127559353688,0.46362131578255955,
KS2014_Intensity C6,0.6274361031779838,,
ZQ2022_N3,,,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,0.6284429424922399,,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,0.5955479398344353,,
JJ2018_Ratio H/M normalized pP1,0.6238914613793368,,
CK2022_16 40-1,0.6306938351136206,,
AH2018_SILAC_IT_2_C,0.6306690955023493,0.4797284052528588,
CK2022_5 40-1,0.631921560828632,,
AH2018_LFQ_3_X,0.6338286644856306,,
UK2020_UA_3,0.613045703570072,,
LY2019_P7-,0.6154728400597682,,
GF2025_P5_Adh,0.633560430048322,0.47780015433422895,
RB2022_1_PostStrength,,0.47554439102566143,
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,,0.4927960141407626,
SR2019_HCC1954_Biol_repl_3,,0.45639095635687416,
CR2017_Ratio Replicate 2.2,0.6211889202293205,0.47350282493440227,
VOI2024_0.1uM 2 h_1 mono,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,
CK2022_11 16-1,0.6363445841571469,,
ZQ2022_C1,,,
CR2017_Ratio Replicate 2.1,0.6283796837717145,0.47563948346280327,
PG2020_Intensity CT_B,0.6245369724719819,,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,0.6460595134091148,,
KS2014_Intensity pY_E5_1,,,
JW2021_Before_3,,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,,,
AH2018_LFQ_3_C,0.6420046956197244,,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,0.6357273987417309,,
YA2020_Reporter_intensity_Cancer_No.4,0.6386989246126853,0.4696221345649505,
KS2014_Intensity pY_E5_2,,,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,0.6159960969256009,0.44342721759390474,
RB2022_2_PreEndurance,,0.46922872519225645,
JW2021_Before_1,,,
KBE2022_Log2_Ex_25_T,0.6281233523628312,0.46074861383720805,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,0.619161170819537,,
FR2021_Intensity.H,,,
CK2022_14 16-1,0.6386565679100437,,
AST2020_anti-CD3+PDL2,0.6125448085993894,,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,0.6280237321894847,0.4702211037734687,
KS2014_Intensity pY_N1,0.63228295468926,,
RB2022_1_RecoveryEndurance,,0.4606626879412077,
FSO2013_Ratio H/M normalized Rep1___2,,,
HS2024_8_I_T1,,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,,
EP2017_Mitotic R#2 log2 ratio,0.6396448365897777,,
AH2018_TMTMS2_1_X,0.632643833059798,0.48913974643156255,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,,,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,,0.470241491800743,
HS2024_6_I_N2,,,
HH2022_Reporter intensity 4,,,
RBK2021_1326T Late,0.6155915938578942,,
TM2022_mock.12h.B,,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,0.6310544996843152,,
HS2024_4_I_T3,,,
AH2018_SILAC_1_X,0.6299910202704951,,
PG2020_Intensity 10h_B,0.6072916485126956,0.45978221920402745,
AH2018_TMTMS3_1_X,0.6413582505625424,0.46443660296715944,
CF2017_FTE 14,0.6311509935607201,,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,0.6193688353405595,,
RKK2015_IKK+TNF-α/IKKb,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,0.6268850669066007,,
SR2019_HCC1419_Biol_repl_3,,,
KBE2022_Log2_Ex_14_T,0.6286846725865387,0.4725811773537401,
EP2017_Untreated R#2 normalized log2 ratio,0.587471620902042,,
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,,
LY2019_P5+,0.6096137171122301,,
HS2024_5_I_N2,,0.47023354904507336,
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,0.6303498883543653,,
AS2011_Ratio H/L Normalized RNAi_2_1,,,
